ABSTRACT
Objective:
The study was conducted to determine upper extremity problems and quality of life in patients with breast cancer who underwent breast surgery and axillary dissection.
Methods:
This descriptive and cross-sectional research was included 64 patients who admitted for outpatient clinic between 01.01.2015-01.01.2016 in university hospital in western of Turkey and previously undergone surgery for breast cancer. The data was collected personal information form, Shoulder Pain and Disability Index (SPADI) the Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire (Q-DASH), Breast Cancer Module Quality of Life Scale (EORTC QLQ-BR23) and Short Form-36 (SF-36). Statistical analyses were performed using descriptive statistics, Chi Ssquare test, Mann Whitney U test, Kruskal Walles test and the Spearman’s correlation coefficient.
Results:
Mean age of the study group was 52.36±12.25 years. It was found that 54.7% of the patients were applied modified radical mastectomy and axillary dissection, and average time passed after surgery 11.27±10.00 months. Affected arm had shoulder pain (53.1%), restrictions on shoulder (51.6%) and lymphedema (21.9%).It was determined that patients were received low scores from SPADI and Q-DASH, and SF-36 physical and mental summary scores of below the average. The EORTC QLQ-BR23 functional status and symptom subscales scores of patients were low.
Conclusion:
It was seen that patients’ quality of life was low, their functional status was poor, and cancer-related symptoms to be less. The working with multidisciplinary team on preoperative and postoperative will help prevent complications and increase the quality of life.
Keywords:
Breast Cancer, extremity problems, quality of life
References
1
Youlden DR. Cramb SM. Yip CH. Baade PD. Incidence and mortality of female breast cancer in the AsiaPacific region. Cancer Biol Med 2014;11(2):101-115.
2
Haydaroğlu A. Meme Kanserinde Epidemiyoloji. Sınıflama ve Evreleme. Turkiye Klinikleri J Radiat Oncol-Special Topics 2015;1(2):1- 6.
3
Lee Y. Mak S. Tse S. Chan S. Lymphedema care of breast cancer patients in a breast care a. clinic: a survey of knowledge and health practise. Support Care Cancer 2001; 9(8): 634-641.
4
Radina E. Armer J. Culbertson S. Dusold J. Post-breast cancer lymphedema: understanding women’s knowledge of their condition. Oncol Nurs Forum2004;31(1):97-104.
5
Gary DE. Lymphedema diagnosis and management. J Am Acad Nurse Pract. 2007; 19(2):72-78.
6
Büyükakıncak Ö. Akyol Y. Özen N ve ark. Meme kanseri olan hastalarda cerrahi sonrası erken dönemde yaşam kalitesi: omuz ağrısı. el kavrama gücü. dizabilite ve emosyonel durum ile ilişkisi. Turk J Phys Med Rehab 2014;60:1-6.
7
Park HJ. Lee HW. Chung SH. Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs 2008; 17(11): 1450-1459.
8
Sakorafas GH. Peros G. Cataliotti L. Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006;15:153-65.
9
Voogd AC. Ververs JM. Vingerhoets AJ. Roumen RM. Coebergh JW. Crommelin MA. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 2003;90(1):76-81.
10
Isaksson G. Feuk B. Morbidity from axillary treatment in breast cancer a follow-up study in a district hospital. Acta Oncol 2000;39(3):335-336.
11
Bosompra K. Ashikaga T. O’Brien PJ. Nelson L. Skelly J. Swelling. numbness. pain. and their relationship to arm function among breast cancer survivors: a disablement process model perspective. Breast J 2002;8(6):338-348.
12
Kwan W. Jackson J. Weir LM. Dingee C. McGregor G. Olivotto IA. Chronic arm morbidity after curative breastcancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002;20(20):4242-4248.
13
Beaulac SM. McNair LA. Scott TE. LaMorte WW. Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg2002;137(11):1253-1257.
14
Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer 2005;13(11):904-911.
15
Ahmed RL. Prizment A. Lazovich D. Schmitz KH. Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study.J Clin Oncol 2008;26(35):5689-5696.
16
Atalay NŞ. Taflan Selçuk S. Ercidoğan Ö ve ark. Meme cerrahisi ve aksiller diseksiyon uygulanan meme kanserli hastalarda üst ekstremite problemlerinin sıklığı ve yaşam kalitesine etkisi. Turk J Phys Med Rehab 2011;57:186-192.
17
Pusic AL. Cemal Y. Albornoz C ve ark. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv 2013;7(1):83-92.
18
Lopez Penha TR. van Bodegraven J. Winkens B ve ark. The quality of life in long-term breast cancer survivors with breast cancer related lymphedema. Acta Chir Belg 2014;114(4):239–244.
19
Paskett ED. Naughton MJ. McCoy TP. Case LD. Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007;16(4):775- 782.
20
Thomas-MacLean R. Miedema B. Tatemichi SR. Breast cancer-related lymphedema: women’s experiences with an underestimated condition. Can Fam Physician 2005;51:246-247.
21
Bumin G. Tüzün EH. Tonga E. The Shoulder Pain and Disability Index (SPADI): Cross-cultural adaptation. reliability. and validity of the Turkish version. J Back Musculoskelet Rehabil 2008; 21: 57–62.
22
Düger T. Yakut E. Öksüz Ç. Yörükan S. Bilgütay BS. Ayhan Ç. Leblebicioğlu G. Kayıhan H. Kırdı N. Yakut Y. Güler Ç. Reliability and validity of the Turkish version of the Disabilities of the Arm. Shoulder and Hand (DASH) Questionnaire. Turk J Phys Med Rehab 2006; 17(3): 99-107.
23
Gummesson C. Ward MM. Atroski I. The shortened disabilities of the arm. shoulder and hand questionnaire (Quick-DASH): validity and reliability based on responses within the full- length DASH. BMC Musculoskelet Disord 2006;7:44.
24
Sprangers MA. Groenvold M. Arraras JI ve ark. The EORTC breast cancerspecific quality-of-life questionnaire modüle: First results from a three-country field study. J Clin Oncol 1996;14(10):2756-2768.
25
Demirci S. Eser E. Ozsaran Z ve ark. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. Asian Pac J Cancer Prev 2011;12(5):1283-1287.
26
Ware JE. Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6): 473-483.
27
Koçyiğit H. Aydemir Ö. Fişek G. Ölmez N. Memiş A. The validity and reliability of Turkish version of the Short Form 36 (SF-36). Turkish Journal Drugs Therapy 1999; 12: 102- 106.
28
Karadibak D. Yıldırım Y. Kara B. Saydam S. Effect of complex decongestive therapy on upper extremity lymphedema. Fizyoter Rehabil 2009;20(1):03- 08.
29
Quiron E. Recognizing and treating upper extremity lymphedema in postmastectomy/lumpectomy patients: A guide for primary care providers. J Am Acad Nurse Pract 201;22(9):450-459.
30
Hidding JT. Beurskens CH. van der Wees PJ. van Laarhoven HW. Nijhuis-van der Sanden MW. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One 2014; 9;9(5):e96748.
31
Ewertz M. Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. a. Acta Oncol 2011;50(2):187-193.
32
Hayes SC. Johansson K. Stout NL ve ark. Upper-body morbidity after breast cancer: Incidence and evidence for evaluation. prevention. and management within a prospective surveillance model of care. Cancer 2012;118(8 suppl):2237-2249.
33
Karki A. Simonen R. Malkia E. Selfe J. Impairments. activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med 2005;37:180-188.
34
Westrup JL. Lash TL. Thwin SS. Silliman RA. Risk of decline in upper-body function a. and symptoms among older breast canser patients. J Gen Intern Med 2006; 21: 327- 333.
35
Lee TS. Kilbreath SL. Refshauge KM. Herbert RD. Beith JM. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 2008;110: 19–37.
36
Lauridsen MC. Overgaard M. Overgaard J. Hessov IB. Cristiansen P. Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol 2008;47(4):569-575.
37
Özçınar B. Güler SA. Özmen V ve ark. Meme kanserinde lokal/bölgesel tedavi sonrası görülen komplikasyonlar ve bunların hasta yaşam kalitesi üzerine etkileri. The Journal of Breast Health 2010; 6(1):9-16.
38
Petrek JA. Senie RT. Peters M. Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001;15;92(6):1368-1377.
39
Clark B. Sitzia J. Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: A three-year follow-up study. QJM 2005; 98(5):343-348.
40
Ugur S. Arıcı C. Yaprak M ve ark. Risk Factors of breast cancer-related lymphedema. Lymphat Res Biol 2013;11(2):72-75.
41
Mak SS. Mo KF. Suen JJ. Chan SL. Ma WL. Yeo W. Lymphedema and quality of life in Chinese women after treatment for breast cancer. Eur J Oncol Nurs2009;13(2):110-115.
42
Soran A. Bulut F. Yıldırım O. Cengiz Ö. Meme kanseri nedeniyle opere edilen hastalarda yaşam kalitesinin SF-36 skalası ile belirlenmesi. Ulusal Cerrahi Dergisi 2000;16(2):109-115.
43
Manandhar S. Shrestha DS. Taechaboonsermsk P. Siri S. Suparp J. Quality of life among breast cancer patients undergoing treatment in national cancer centers in Nepal. Asian Pac J Cancer Prev 2014;15(22):9753-9757.
44
Almutairi KM. Mansour EA. Vinluan JM. A cross-sectional assessment of quality of life of breast cancer patients in Saudi Arabia. Public Health2016;136:117-125.
45
Dawes DJ. Meterissian S. Goldberg M. Mayo NE. Impact of lymphoedema on arm function and health-related quality of life in women following breast canser surgery. J Rehabil Med 2008;40(8):651-658.
46
Smoot B. Wong J. Cooper B ve ark. Upper extremity impairments in women with or without lymphedema following breast canser treatment. J Cancer Surviv. 2010;4(2):167-178.
47
Torres-Lacomba M. Sánchez-Sánchez B. Prieto-Gómez V ve ark. Spanish cultural adaptation and validation of the shoulder pain and disability index. and the oxford shoulder score after breast cancer surgery. Health Qual Life Outcomes 2015; 23;13:63.
